__NUXT_JSONP__("/drugs/Anti-CD33_Monoclonal_Antibody_BI_836858", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"An engineered, fully human, immunoglobulin (Ig) G1 anti-CD33 monoclonal antibody, with potential antineoplastic activity. Upon administration, anti-CD33 monoclonal antibody BI 836858 induces an antibody-dependent cellular cytotoxicity (ADCC) against CD33-expressing tumor cells, leading to cell death. CD33, a cell surface antigen expressed on normal non-pluripotent hematopoietic stem cells, is overexpressed on myeloid leukemia cells.",fdaUniiCode:"JA7I0QFJ17",identifier:"C116737",preferredName:c,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:[c,"BI 836858","BI-836858"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAnti-CD33_Monoclonal_Antibody_BI_836858",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Anti-CD33_Monoclonal_Antibody_BI_836858","Anti-CD33 Monoclonal Antibody BI 836858","2021-10-30T13:19:14.823Z")));